Web based pathology assessment in RTOG 98-04

Journal of Clinical Pathology

Volumn 67, Issue 9, 2014, Pages 777-780

  Woodward, Wendy A ^a   Sneige, Nour ^a   Winter, Kathryn ^b   Kuerer, Henry Mark ^a   Hudis, Clifford ^c   Rakovitch, Eileen ^d   Smith, Barbara L ^e   Pierce, Lori J ^f   Germano, Isabelle ^g   Pu, Anthony T ^h   Walker, Eleanor M ⁱ   Grisell, David Lawrence ^j   White, Julia R ^k   McCormick, Beryl ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b RTOG Statistical Center   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h Radiological Associates of Sacramento Medical Group Inc   (United States)

ⁱ HENRY FORD HOSPITAL   (United States)

^j Cancer Centers of the Carolinas   (United States)

^k Stephanie Spielman Comprehensive Breast Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; HUMAN; INTERNET; INTRADUCTAL CARCINOMA; PATHOLOGY; PRIORITY JOURNAL; TEACHING; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CLASSIFICATION; EDUCATION; FEMALE; MAMMOGRAPHY; MEDICAL EDUCATION; PREDICTIVE VALUE; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMPUTER-ASSISTED INSTRUCTION; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; INTERNET; MAMMOGRAPHY; NEOPLASM GRADING; PATHOLOGY, CLINICAL; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84906939841     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202370     Document Type: Article

References (23)

1. Lagios MD, Margolin FR, Westdahl PR, et al. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-24. (Pubitemid 19050259)
2. Silverstein MJ, Cohlan BF, Gierson ED, et al. Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 1992;28:630-4.
3. Solin LJ, McCormick B, Recht A, et al. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Cancer J Sci Am 1996;2:158-65.
4. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006;24:3381-7. (Pubitemid 46638893)
5. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-71. (Pubitemid 32366979)
6. Bijker N, Peterse JL, Duchateau L, et al. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 2001;84:539-44. (Pubitemid 32215883)
7. Correa C, McGale P, Taylor C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010;2010:162-77.
8. Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 2006;45:536-43. (Pubitemid 44167203)
9. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6. (Pubitemid 23151917)
10. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-52. (Pubitemid 28135585)
11. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353:1993-2000. (Pubitemid 29271743)
12. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 2008;26:1247-52.
13. Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000;355:528-33. (Pubitemid 30088672)
14. Ringberg A, Nordgren H, Thorstensson S, et al. Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast - results from the Swedish randomised trial. Eur J Cancer 2007;43:291-8. (Pubitemid 46123991)
15. Sneige N, Lagios MD, Schwarting R, et al. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. Hum Pathol 1999;30:257-62. (Pubitemid 29125143)
16. Committee TCC. Consensus conference on the classification of ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev 1997;80:1789-802.
17. Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 2009;133:1515-38.
18. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999;86:429-38. (Pubitemid 29347405)
19. Solin LJ, Kurtz J, Fourquet A, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996;14:754-63. (Pubitemid 26085518)
20. Wallis MG, Clements K, Kearins O, et al. The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. Br J Cancer 2012;106:1611-17.
21. Dignam JJ, Bryant J, Wieand HS, et al. Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project. Control Clin Trials 1998;19:575-88. (Pubitemid 29057723)
22. Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 2010;28:3762-9.
23. Yi M, Meric-Bernstam F, Kuerer HM, et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 2012;30:600-7.